LINKER-MM1

First in Human (FIH) Study of Linvoseltamab (REGN5458) in Patients With Relapsed or Refractory Multiple Myeloma

Near Add Your Location

Sorting 14 by

Norton Cancer Institute (St. Matthews)
St. Matthews Campus
Louisville, KY
  • Accepting patients
  • Show Principal Investigator
Barbara Ann Karmanos Cancer Institute
Wayne State University
Detroit, MI
  • Accepting patients
  • Show Principal Investigator
Rutgers Cancer Institute of New Jersey
Rutgers, The State University of New Jersey
New Brunswick, NJ
  • Accepting patients
  • Show Principal Investigator
Mount Sinai Hospital
Tisch Cancer Institute
New York, NY
  • Accepting patients
  • Show Principal Investigator
Herbert Irving Comprehensive Cancer Center (Columbia University)
Columbia University Medical Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients
  • Show Principal Investigator
Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Accepting patients
  • Show Principal Investigator
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
  • Show Principal Investigator
Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
  • Accepting patients
  • Show Principal Investigator
MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.